Abstract: P948 EZETIMIBE(E)+ATORVASTATIN(A) VS. A UP-TITRATION IN MODERATELY HIGH CHD RISK (MHR) OR HIGH CHD RISK (HR) PATIENTS: EFFECTS OF BASELINE BODY MASS INDEX (BMI), FASTING BLOOD SUGAR (FBS) AND HS-CRP
Bays, H, Conard, S, Leiter, L, Bird, S, Lin, J, Lowe, R, Shah, A, Tershakovec, AVolume:
10
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/S1567-5688(09)71069-4
Date:
June, 2009
File:
PDF, 215 KB
english, 2009